Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106443985 | 10644398 | 5 | F | 20160801 | 20141210 | 20160803 | EXP | US-GLAXOSMITHKLINE-US2014GSK033502 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106443985 | 10644398 | 1 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | UNK, U | U | AZP6389 | 21077 | INHALATION POWDER | |||||||
| 106443985 | 10644398 | 2 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 4ZP6473 | 21077 | INHALATION POWDER | ||||||||
| 106443985 | 10644398 | 3 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 5ZT2436 | 21077 | INHALATION POWDER | ||||||||
| 106443985 | 10644398 | 4 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 5ZP2436 | 21077 | INHALATION POWDER | ||||||||
| 106443985 | 10644398 | 5 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | UNKNOWN | 21077 | INHALATION POWDER | ||||||||
| 106443985 | 10644398 | 6 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Unknown | UNK, U | U | KY4C | 0 | ||||||||
| 106443985 | 10644398 | 7 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK | U | UNKNOWN | 0 | |||||||||
| 106443985 | 10644398 | 8 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | UNK | U | UNKNOWN | 0 | INHALATION POWDER | ||||||||
| 106443985 | 10644398 | 9 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | U | 0 | INHALATION POWDER | ||||||||||
| 106443985 | 10644398 | 10 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | UNK, U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106443985 | 10644398 | 1 | Asthma |
| 106443985 | 10644398 | 2 | Chronic obstructive pulmonary disease |
| 106443985 | 10644398 | 6 | Chronic obstructive pulmonary disease |
| 106443985 | 10644398 | 7 | Asthma |
| 106443985 | 10644398 | 8 | Chronic obstructive pulmonary disease |
| 106443985 | 10644398 | 9 | Asthma |
| 106443985 | 10644398 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106443985 | 10644398 | HO |
| 106443985 | 10644398 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106443985 | 10644398 | Bronchitis | |
| 106443985 | 10644398 | Colostomy | |
| 106443985 | 10644398 | Dehydration | |
| 106443985 | 10644398 | Drug dose omission | |
| 106443985 | 10644398 | Gastric disorder | |
| 106443985 | 10644398 | Lower respiratory tract congestion | |
| 106443985 | 10644398 | Malaise | |
| 106443985 | 10644398 | Pneumonia | |
| 106443985 | 10644398 | Vasculitis | |
| 106443985 | 10644398 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106443985 | 10644398 | 1 | 2009 | 0 | ||
| 106443985 | 10644398 | 5 | 2008 | 0 | ||
| 106443985 | 10644398 | 7 | 2008 | 0 | ||
| 106443985 | 10644398 | 8 | 2008 | 0 |